Edition:
United Kingdom

Skyline Medical Inc (SKLN.OQ)

SKLN.OQ on NASDAQ Stock Exchange Capital Market

1.07USD
15 Dec 2017
Change (% chg)

-- (--)
Prev Close
$1.07
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
45,642
52-wk High
$3.84
52-wk Low
$1.00

Select another date:

Fri, Dec 8 2017

BRIEF-Skyline Medical Files For Resale Of Up To 1.9 Mln Shares By Selling Stockholder

* SKYLINE MEDICAL INC FILES FOR RESALE OF UP TO 1.9 MILLION SHARES OF CO'S COMMON STOCK BY THE SELLING STOCKHOLDER - SEC FILING Source text: (http://bit.ly/2BQ55m2) Further company coverage:

BRIEF-Skyline Medical Asking Shareholders To Approve Proposed Increase In Number Of Shares Of Common Stock

* SKYLINE MEDICAL INC - ASKING SHAREHOLDERS TO APPROVE PROPOSED INCREASE IN NUMBER OF AUTHORIZED SHARES OF COMMON STOCK FROM 24 MILLION TO 50 MILLION Source text for Eikon: Further company coverage:

BRIEF-Skyline Medical and Helomics Announce Joint Strategic Partnership With GLG Pharma

* SKYLINE MEDICAL AND HELOMICS ANNOUNCE A JOINT STRATEGIC PARTNERSHIP WITH GLG PHARMA

BRIEF-Skyline Medical, Helomics Corp sign joint venture to commercialize D-CHIP platform

* Skyline Medical and Helomics Corporation sign joint venture term sheet to build-out and commercialize the D-CHIP platform

BRIEF-Skyline Medical reports Q3 loss per share $0.16

* Skyline Medical reports 2017 third quarter financial results

BRIEF-Skyline Medical partners with Device Technologies

* Says ‍has partnered with Device Technologies to market STREAMWAY System in Australia, New Zealand, Fiji and Pacific Islands​ Source text for Eikon: Further company coverage:

BRIEF-Skyline Medical proposes two joint ventures

* Two proposed joint ventures with Helomics Corporation and Cytobioscience​

BRIEF-Skyline Medical signs distribution agreements in Canada and Switzerland

* Skyline Medical Inc expands international presence by signing distribution agreements in Canada and Switzerland

BRIEF-Skyline Medical enters into strategic collaboration with Helomics to develop next generation of personalized cancer diagnostics

* Skyline Medical Inc. enters into strategic collaboration with Helomics to develop next generation of personalized cancer diagnostics Source text for Eikon: Further company coverage:

BRIEF-Skyline Medical provides update on pending merger with CytoBioscience

* Skyline Medical provides update on pending merger with CytoBioscience

Select another date: